METHODS FOR DIAGNOSING AND MONITORING TREATMENT OF LEWY BODY DEMENTIA BY ASSESSING DOPAMINE TRANSPORTER LEVEL

• 1. 评估胆红素体内毒性水平以及诊断胆红素神经毒性风险增加的方法和设备 [P] . 中国专利： CN110622001A . 2019-12-27
• 2. 一种用于口语测试的文本朗读水平自动评估诊断方法 [P] . 中国专利： CN101739868B . 2012.03.28
• 3. Method for the diagnosis of Lewy body dementia by assessing dopamine transporter levels and the monitoring of Lewy body dementia treatment [P] . 日本专利： JP2011502966A . 2011-01-27

  机译： 通过评估多巴胺转运蛋白水平和监测路易体痴呆症来诊断路易体痴呆的方法

• 4. METHODS FOR DIAGNOSING AND MONITORING TREATMENT OF LEWY BODY DEMENTIA BY ASSESSING DOPAMINE TRANSPORTER LEVEL [P] . 美国专利： US2016121003A1 . 2016-05-05

  机译： 评估多巴胺转运体水平诊断和监测体质痴呆的方法。

• 5. METHODS FOR DIAGNOSING AND MONITORING TREATMENT OF LEWY BODY DEMENTIA BY ASSESSING DOPAMINE TRANSPORTER LEVEL [P] . 美国专利： US2010312105A1 . 2010-12-09

  机译： 评估多巴胺转运体水平诊断和监测体质痴呆的方法。

• 1. Biomarkers for the diagnosis of Alzheimer''''s disease, dementia Lewy body, frontotemporal dementia and vascular dementia [J] . Joshua Marvin Anthony Maclin, Tao Wang, Shifu Xiao 综合精神医学（英文） . 2019,第001期
• 2. Correlation between Alzheimer’s Disease and Dementia with Lewy Bodies Scores Using VSRAD Advance [J] . Yukinori Okada, Norikazu Ohno, Koji Tanaka 阿尔茨海默氏病研究进展（英文） . 2021,第003期
• 3. Diagnosing Graves’ Disease and Non-Graves Hyperthyroidism Using TSH Receptor Antibody Test versus Non-TSH Receptor Antibody Test Methods of Diagnosis [J] . Mohammed Qader Meena 内分泌与新陈代谢疾病期刊（英文） . 2020,第002期
• 4. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study. [J] . Roselli F, Pisciotta NM, Perneczky R Movement disorders . 2009,第14期
• 5. The role of 123I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies [J] . Angelo Antonini Neuropsychiatric Disease and Treatment . 2007,第3期
• 6. A comparison of striatal dopamine transporter function between dementia with lewy bodies and Parkinson disease with dementia [J] . Y. Kajimoto, S. Yorozu, M. Minamino, Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 2017,第期
• 7. Module differences of glucose metabolic brain network among Alzheimer’s disease, Parkinson’s disease dementia, Lewy body dementia and health control* [C] . Danyan Chen, Jiehui Jiang, Ping Wu, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2018
• 8. Differences in caregiver grief and burden between Dementia with Lewy Bodies, dementia of the Alzheimer's type, and dementia associated with Parkinson's Disease [D] . Rigby, Taylor. 2016
• 9. The role of 123I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies [O] . Angelo Antonini 2007
• 10. Is dopamine transporter invariably impaired at the time of diagnosis in dementia with Lewy bodies? [O] . Nobili, Flavio, Arnaldi, Dario, Morbelli, Silvia 2016

• 1. Biomarkers for the diagnosis of Alzheimer's disease, dementia Lewy body, frontotemporal dementia and vascular dementia [J] . Joshua Marvin Anthony Maclin ,Tao Wang ,Shifu Xiao . 综合精神医学 . 2019,第001期
• 2. Recent progress and concerns in dementia: Distinguishing Alzheimer's disease and dementia with Lewy bodies via biochemical markers in the cerebrospinal fluid [J] . Peizhong Mao . 生物化学进展（英文） . 2012,第2期
• 3. 使用不同诊断方法评估猪群感染猪瘟病毒后的疫苗应答水平 [C] . RJ.Pi(n)eros JD Mogollón ,周斌 . 第22届国际猪兽医协会大会（IPVS2012） . 2012
• 4. 动态监测脓毒症患者血浆miR-146a表达水平与诊断、病情评估及预后的研究 [A] . 商嘉 . 2017